SamaCare Named in Inc’s Annual 5,000 List

SamaCare is ranked 578 on Inc's annual 5,000 list.
Stock.adobe.com

SamaCare announced that it is officially ranked on Inc.’s annual 5,000 list.¹ The cloud-based patient access platform for specialty medications came in at number 578 on the list.

In a press release, SamaCare founder and CEO Syam Palkurthy said, “SamaCare's growth is directly tied to real human impact—and that's what truly motivates us. SamaCare helps remove the administrative barriers that prevent patients from accessing life-saving therapies. We're proud to work alongside passionate healthcare providers and pharmaceutical partners who share our commitment to improving and extending lives."

In the same press release, Questa Capital’s managing partner Bradley Sloan added, “It's remarkable to see SamaCare reach the #94 spot in California's Inc. 5000 rankings—a state that's home to some of the world's most innovative and well-funded private companies. Equally impressive is their #68 ranking in the healthcare services category, competing alongside massive incumbents. SamaCare's success isn't just their own—it benefits the entire healthcare ecosystem. When patients get on prescribed therapies without unnecessary delay, we all win."

Inc.’s editor in chief, Mike Hofman, also said, “Making the Inc. 5000 is always a remarkable achievement, but earning a spot this year speaks volumes about a company's tenacity and clarity of vision. These businesses have thrived amid rising costs, shifting global dynamics, and constant change. They didn't just weather the storm—they grew through it, and their stories are a powerful reminder that the entrepreneurial spirit is the engine of the U.S. economy."

Earlier this summer, SamaCare announced that it had completed one million medical benefit drug prior authorizations using a combination of human expertise and AI.²

In a press release issued at the, Palakurthy said, “We're excited to reach this milestone in our journey to help providers streamline the Script-to-Therapy process, and get patients the critical treatments they need, when they need them. By combining the power of AI and human expertise, we can leverage insights from over one million resolved prior authorizations to make SamaCare exponentially better at understanding and eliminating the friction patients and providers face from the time a diagnosis is made to the time treatment is administered."

Palakurthy continued, “The reasons why a prior authorization is delayed or even denied are often vague and perplexing. SamaCare provides in-workflow intelligence to help practices proactively avoid common mistakes that lead to delays and denials, and helps pharmaceutical manufacturers gain insight into access challenges associated with their product."

Sources

1. SamaCare Ranks No. 578 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies. SamaCare. August 12, 2025. https://www.prnewswire.com/news-releases/samacare-ranks-no-578-on-the-2025-inc-5000-list-of-americas-fastest-growing-private-companies-302526861.html
2. SamaCare Celebrates One Million Medical Benefit Drug Prior Authorizations, Made Fast, Easy, and Accurate with AI. SamaCare. June 12, 2025. Accessed August 12, 2025. https://www.prnewswire.com/news-releases/samacare-celebrates-one-million-medical-benefit-drug-prior-authorizations-made-fast-easy-and-accurate-with-ai-302479783.html